全基因组的表皮质分析揭示了与帕金森病风险相关的显著表皮质信号
Alejandro Cisterna-Garcia1, Bernabe I Bustos2, Sara Bandres-Ciga3
1Departamento de Ingeniería de la Información y las Comunicaciones, Universidad de Murcia, Murcia 30100, Spain.
Brain : a journal of neurology
|December 10, 2024
概括
这项研究引入了VARI3,一种新方法来检测帕金森病中的遗传相互作用 (epistasis). 它识别和复制了新的表皮病信号,进步了我们对疾病复杂遗传结构的理解.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了与帕金森病 (PD) 相关的常见变异.
- 很大一部分PD遗传性仍然无法通过单独的常见变异来解释.
- 表观症,或基因与基因的相互作用,是这种遗传性缺失的潜在贡献者.
研究的目的:
- 开发和应用一种新的全基因组表皮病查管道 (VARI3),用于帕金森病.
- 为了识别和复制与PD风险相关的表皮性相互作用.
- 探索已识别的表现性信号的功能影响.
主要方法:
- 通过可变值 (VARI3) 管道开发变异-变异相互作用,用于全基因组表皮病查.
- 应用VARI3到不同的帕金森病GWAS队列 (14发现,4复制).
- 功能和奥米克数据分析,以评估已识别的表皮病信号的影响.
主要成果:
- 在发现阶段确定了14个重要的候选变异-变异相互作用.
- 在SNCA附近,在MAPT内部和WNT3位置复制了三个表观信号.
- 在具有欧洲和美洲原住民血统的个体中观察到的表性影响.
- 在脑组织中检测到显著的单变体表达定量特征位点 (eQTLs) 和血液中的表达性eQTLs.
- 在PD相关的路径和本体学中发现了已识别的信号的丰富.
结论:
- 发现了与帕金森病风险相关的新型表观信号,并在多种祖先中复制.
- 这些发现凸显了在PD遗传架构中表观症的重要性.
- 鉴定到的信号被丰富了与帕金森病病原体相关的途径.
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Epistasis Analysis
4.9K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
4.9K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Human Genetics
534
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
534
Single Nucleotide Polymorphisms-SNPs
14.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.0K
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479


